Health Care: Drugs

Acorda Therapeutics Inc. (ACOR: NASDAQ)

$32.94 0.41 | 1.26%
05/17/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 305.81M 292.24M 191.01M 54.67M
Cost of Sales 48.53M 55.09M 27.00M 3.60M
Gross Operating Profit 257.28M 237.15M 164.01M 51.07M
Selling, General, and Administrative Expenses 168.69M 148.51M 133.32M 89.93M
Research & Development 53.88M 42.11M 30.60M 34.61M
Operating Income before D & A (EBITDA) 34.71M 46.53M 89.66K -73.47M
Depreciation & Amortization 9.11M 11.48M 8.52M 7.79M
Interest Income 552.00K 552.00K 574.84K 1.75M
Other Income - Net -6.00K -18.00K 8.26K -18.15K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 26.15M 35.59M -7.85M -79.53M
Interest Expense 1.88M 3.57M 3.92M 4.41M
Pre-Tax Income 24.27M 32.02M -11.77M -83.94M
Income Taxes -130.69M 1.41M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 154.96M 30.60M -11.77M -83.94M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 154.96M 30.60M -11.77M -83.94M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 154.96M 30.60M -11.77M -83.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 154.96M 30.60M -11.77M -83.94M
Preferred Dividends
Net Income Available To Common 154.96M 30.60M -11.77M -83.94M
Basic EPS from Continuing Ops. 3.93 0.78 -0.31 -2.22
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.93 0.78 -0.31 -2.22
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.93 0.78 -0.31 -2.22
Basic Normalized Net Income/Share 3.93 0.78 -0.31 -2.22
EPS fr Continuing Ops. 3.84 0.76 -0.31 -2.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.84 0.76 -0.31 -2.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.84 0.76 -0.31 -2.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.84 0.76 -0.31 -2.22
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACOR

View All

Latest ACOR Headlines from TheStreet

More Financial News for ACOR

Press Releases for ACOR

See All Press Releases

Partner Headlines for ACOR

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter